Search Results

Multiple drugs: Persistent COVID-19, off-label use, vaccination failure and lack of efficacy.

Subjects: *RITUXIMAB; *OFF-label use (Drugs); *DRUGS

• Source: Reactions Weekly. 3/9/2024, Vol. 1998 Issue 1, p364-365. 2p.

Record details

Venetoclax plus rituximab for chronic lymphocytic leukaemia.

• Authors : Stirrups R

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic/Bridged Bicyclo Compounds, Heterocyclic/Bridged Bicyclo Compounds, Heterocyclic/*administration & dosage ; Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy

• Source: The Lancet. Oncology [Lancet Oncol] 2018 May; Vol. 19 (5), pp. e233. Date of Electronic Publication: 2018 Mar 29.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Multiple drugs: Pain at injection site, malaise and lack of efficacy: 12 case reports.

Subjects: *RITUXIMAB; *INJECTIONS; *CHRONICALLY ill

• Source: Reactions Weekly. Nov2023, Vol. 1982 Issue 1, p297-298. 2p.

Record details

Immunosuppressants/rituximab: No response and off label use: 21 case reports.

Subjects: *RITUXIMAB; *OFF-label use (Drugs); *IMMUNOSUPPRESSIVE agents

• Source: Reactions Weekly. May2023, Vol. 1955 Issue 1, p203-204. 2p.

Record details

Rapid Rituximab: An Inpatient Pilot Project to Increase Education and Use Among Oncology Nurses

• Authors : Schade, Casey

• Source: Clinical Journal of Oncology Nursing. August 2022, Vol. 26 Issue 4, p433, 5 p.

Record details

Artiva Updates on FDA Clearance of IND for AlloNK Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

• Source: Health & Beauty Close-Up. August 28, 2023

Record details

Specialty Drugs Driving Increase in Hospital Pharmacy Spend.

• Authors : Myshko, Denise

Subjects: *INVENTORY shortages; *COST control; *ECONOMICS

• Source: Formulary Watch. 8/23/2023, p2-2. 1p.

Record details

Pre-infusion checklist for rituximab in pemphigus vulgaris patients: clinical audit

• Authors : Sagheer, Farah; Kayani, Maham; Khalil, Elma

• Source: Journal of Pakistan Medical Association. August 31, 2023, Vol. 73 Issue 8, 1663

Record details

Rituximab Not Noninferior to Ocrelizumab for Relapsing-Remitting MS

• Source: MPR Monthly Prescribing Reference. June 16, 2023

Record details

Maintenance rituximab in mantle-cell lymphoma.

• Authors : Burki TK

Subjects: Maintenance Chemotherapy*; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use ; Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/Lymphoma, Mantle-Cell/*therapy

• Source: The Lancet. Oncology [Lancet Oncol] 2017 Nov; Vol. 18 (11), pp. e647. Date of Electronic Publication: 2017 Oct 05.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details